Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.48 |
| ▸ | FER | P16591 | 1/20 | 0.48 |
| ▸ | LTK | P29376 | 1/20 | 0.48 |
| ▸ | CDK8 | P49336 | 1/20 | 0.48 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.48 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.48 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.46 |
| ▸ | TNKS2 | Q9H2K2 | 6/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | S100A4 | P26447 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19568178 | 1.00 | TSHR (0.50) | TSHRLMNAPDGFRAFERLTK | |
| SCHEMBL21135350 | 0.88 | LMNA (0.42) | TSHRLMNAPDGFRAFERLTK | |
| SCHEMBL19854691 | 0.83 | PTPRC (0.46) | TSHRLMNAPDGFRAFERLTK | |
| SCHEMBL21135597 | 0.79 | RET (0.42) | TSHRLMNAPDGFRAFERLTK | |
| SCHEMBL9899341 | 0.78 | IDO1 (0.45) | TSHRLMNAPDGFRAFERLTK | |
| SCHEMBL21135349 | 0.78 | L3MBTL1 (0.45) | TSHRLMNAPDGFRAFERLTK | |
| SCHEMBL16747960 | 0.76 | MEN1 (0.48) | LMNAGSK3BMAOAKMT2AMEN1 | |
| SCHEMBL19492450 | 0.76 | TSHR (0.47) | TSHRLMNAPDGFRAFERLTK | |
| SCHEMBL5807797 | 0.76 | LMNA (0.47) | TSHRLMNAPDGFRAFERLTK | |
| SCHEMBL31739367 | 0.76 | TSHR (0.47) | TSHRLMNAPDGFRAFERLTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0835093-B1 | HAIR DYE AGENTS WITH AT LEAST ONE CONDITIONER | HANS SCHWARZKOPF & HENKEL GMBH (DE) | 2004-03-10 | — | — | EP | claimed |
| EP-0835093-A1 | HAIR DYE AGENTS WITH AT LEAST ONE CONDITIONER | Hans Schwarzkopf GmbH & Co. KG (DE) | 1998-04-15 | — | — | EP | claimed |
| WO-1997001323-A1 | HAIR DYE AGENTS WITH AT LEAST ONE CONDITIONER | HANS SCHWARZKOPF GMBH (DE) | 1997-01-16 | — | — | WO | claimed |
| US-20220136024-A1 | PROTECTING GROUP CHEMISTRY FOR CLEAN, REDUCTANT-FREE DYEING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-05-05 | — | — | US | disclosed |
| US-11203774-B2 | Protecting group chemistry for clean, reductant-free dyeing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-12-21 | — | — | US | disclosed |
| US-11166934-B2 | Pharmaceutical composition for preventing or treating allergic diseases such as asthma or atopy including baicalein as active ingredient | AZCURIS CO., LTD. (KR) | 2021-11-09 | — | — | US | disclosed |
| US-20210214888-A1 | PROCESS FOR DYEING TEXTILES AND ENZYMES USED THEREIN | SANKO TEKSTIL ISLETMELERI SAN. VE TIC. A.S. (TR) | 2021-07-15 | — | — | US | disclosed |
| US-20200352868-A1 | CAPSULE FOR TREATING ULCERATIVE COLITIS | FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE (JP) | 2020-11-12 | — | — | US | disclosed |
| US-20200345645-A1 | COMPOSITIONS COMPRISING INDIGO AND/OR AN INDIGO DERIVATIVE AND METHODS OF USE THEREOF | AZORA THERAPEUTICS, INC. | 2020-11-05 | — | — | US | disclosed |
| US-20200325516-A1 | PROTECTING GROUP CHEMISTRY FOR CLEAN, REDUCTANT-FREE DYEING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2020-10-15 | — | — | US | disclosed |
| US-10738192-B2 | Process for the preparation of indigo carmine | DISHMAN CARBOGEN AMCIS LIMITED (IN) | 2020-08-11 | — | — | US | disclosed |
| US-10704070-B2 | Protecting group chemistry for clean, reductant-free dyeing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-07-07 | — | — | US | disclosed |
| US-10287601-B2 | Indole-derived compound production | BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) | 2019-05-14 | — | — | US | disclosed |
| US-20180037917-A1 | PROTECTING GROUP CHEMISTRY FOR CLEAN, REDUCTANT-FREE DYEING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-02-08 | — | — | US | disclosed |
| US-20170204424-A1 | INDOLE-DERIVED COMPOUND PRODUCTION | BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIV (US) | 2017-07-20 | — | — | US | disclosed |
| EP-0835093-B1 | HAIR DYE AGENTS WITH AT LEAST ONE CONDITIONER | HANS SCHWARZKOPF & HENKEL GMBH (DE) | 2004-03-10 | — | — | EP | disclosed |
| US-6129770-A | HAIR COLOR TREATMENT IMPROVING THE STRUCTURE OF THE HAIR DURING THE ACTUAL COLORING PROCESS AND ELIMINATING THE NEED FOR THE USUAL POST-COLORING TREATMENTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (KGAA) (DE) | 2000-10-10 | — | — | US | disclosed |
| EP-0835093-A1 | HAIR DYE AGENTS WITH AT LEAST ONE CONDITIONER | Hans Schwarzkopf GmbH & Co. KG (DE) | 1998-04-15 | — | — | EP | disclosed |
| WO-1997001323-A1 | HAIR DYE AGENTS WITH AT LEAST ONE CONDITIONER | HANS SCHWARZKOPF GMBH (DE) | 1997-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10287601-B2 | Indole-derived compound production | INMT, IDO1, IDO2 | TSHR 2039/4885LMNA 4227/4885PDGFRA 3865/4885 |
| US-20200352868-A1 | CAPSULE FOR TREATING ULCERATIVE COLITIS | SI, SLC10A2, ALPI | TSHR 4188/4885LMNA 4423/4885PDGFRA 4619/4885 |
| US-20170204424-A1 | INDOLE-DERIVED COMPOUND PRODUCTION | INMT, IDO1, IDO2 | TSHR 2039/4885LMNA 4227/4885PDGFRA 3865/4885 |
| US-11166934-B2 | Pharmaceutical composition for preventing or treating allergic diseases such as asthma or atopy including baicalein as active ingredient | TSLP, JAK1, STAT3 | TSHR 1844/4885LMNA 4400/4885PDGFRA 1238/4885 |
| US-20200345645-A1 | COMPOSITIONS COMPRISING INDIGO AND/OR AN INDIGO DERIVATIVE AND METHODS OF USE THEREOF | AHR, ARNT, IDO1 | TSHR 2322/4885LMNA 3428/4885PDGFRA 3281/4885 |
| US-10738192-B2 | Process for the preparation of indigo carmine | CARM1, IPO5, INMT | TSHR 3674/4885LMNA 3957/4885PDGFRA 2774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.